Themis Medicare revises preferential issue price to ₹102.87 per warrant
Themis Medicare Limited's Preferential Issue Committee revised the issue price for Convertible Equity Warrants to ₹102.87, up from ₹100. The allotment is to Vividhmargi Investments Private Limited and is subject to shareholder and exchange approvals.
The preferential issue aims to raise capital, which can impact the company's financial structure and growth prospects. The revision in price, although minor, is a material fact related to this fundraising activity.
The revision of the issue price is a procedural update and does not significantly alter the company's financial outlook or operational performance. It is a neutral adjustment within the ongoing preferential issue process.
Themis Medicare Limited announced that its Preferential Issue Committee, in a meeting held on March 10, 2026, adopted a modified pricing certificate. The certificate, issued by Mr. Abhishek Wagh, Practicing Company Secretaries, indicated a minimum issue price of ₹102.87 per Convertible Equity Warrant.
Consequently, the committee revised the issue price from the earlier ₹100 to ₹102.87 per warrant. This revision is subject to the approval of the shareholders and the stock exchanges (BSE Limited and NSE).
The company also approved a corrigendum to the Postal Ballot Notice dated February 25, 2026. The preferential allotment involves the issue of up to 4.99% of total shareholding, equivalent to 45,95,795 equity shares, to Vividhmargi Investments Private Limited. The total amount will be decided at the time of allotment.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.